Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

Despite the advent of several new treatment options over the past years, advanced/metastatic prostate carcinoma (PCa) still remains incurable, which justifies the search for novel targets and therapeutic molecules. Nucleophosmin (NPM1) is a shuttling nucleoprotein involved in tumor growth and its ta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Destouches, Damien, Sader, Maha, Terry, Stéphane, Marchand, Charles, Maillé, Pascale, Soyeux, Pascale, Carpentier, Gilles, Semprez, Fannie, Céraline, Jocelyn, Allory, Yves, Courty, José, De La Taille, Alexandre, Vacherot, Francis
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342486/
https://ncbi.nlm.nih.gov/pubmed/26993766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados